Effects of 5'-DFUR and OK-432 on cytokines and thymidine phosphorylase in tumor tissue of gastric cancer patients

Anticancer Research

Volumn 17, Issue 3 C, 1997, Pages 2313-2318

  Ohwada, Susumu ^a   Ogawa, Tetsushi ^a   Izumi, Masaru ^a   Inoue, Tomohiro ^a   Teshigawara, Osamu ^a   Ikeya, Toshiroh ^a   Kusaba, Teruo ^a   Roppongi, Takashi ^a   Iino, Yuichi ^a   Morishita, Yasuo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

5' DFUR; Cytokines; Gastric cancer; OK 432; TdR pase

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL DERIVATIVE; INTERLEUKIN 1ALPHA; PICIBANIL; THYMIDINE PHOSPHORYLASE; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GASTRECTOMY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; STOMACH CANCER;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTOKINES; ENZYME INDUCTION; FLOXURIDINE; GASTRECTOMY; GENE EXPRESSION; HUMANS; INTERLEUKIN-1; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PICIBANIL; STOMACH; STOMACH NEOPLASMS; THYMIDINE PHOSPHORYLASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030860872     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Cook AP, Holman MJ, Kramer MJ, Trown PW: Fluorinated pyrimidine nucleosides. 3, Synthesis and anti-tumor activity of a series of a 5′-deoxy-5-fluoropyrimidines. J Med Chem 22: 1330-1335, 1979.
2. Ishitsuka H, Miwa M, Takemoto K, Fukuoka K, Itoga A, Maruyama H: Role of uridine phosphorylase for antitumor activity of 5′-deoxy-5- fluorouridine. Jpn J Cancer Res 71: 112-123, 1980.
3. Kono A, Hara Y, Sugata S, Karube Y, Matsushima Y, Ishitsuka H: Activation of 5′-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors. Chem Pharm Bull 31: 175-178, 1983.
4. Elias L, Crissman HA: Interferon effects upon the adcnocarcinoma 38 and HL60 cell lines, antiproliferative responses and synergistic interactions with halogenated pyrimidine antimetabolites. Cancer Res 48: 4868-4873, 1988.
5. Wadler S. and Schwartz EL: Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies, a review. Cancer Res 50: 3473-3486, 1990.
6. Eda H, Fujimoto K, Watanabe S, Ura M, Hino A, Tanaka Y, Wada K, Ishitsuka H: Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5- fluorouridine. Cancer Chemother Pharmacol 32: 333-338, 1993.
7. Eda H, Fujimoto K, Watanabe S, Ishikawa T, Ohiwa T, Tatsuno K, Tanaka Y, Ishitsuka H: Cytokines induce uridine phosphorylase in mouse colon 26 carcinoma cells and make the cells more susceptible to 5′-deoxy-5-fluorouridine. Jpn J Cancer Res 84: 341-347, 1993.
8. Schwartz EL, Huffman M, O'Conner CJ, Wadler S: Stimulation of 5- fluorouracil metabolic activation by interferon-a in human colon carcinoma cells. Biochem Biophys Res Commun 182: 1232-1239, 1992.
9. Kim JP, Kwon OJ, Oh ST, Yang HK: Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer. Ann Surg 216: 269-279, 1992.
10. Kyoto Research Group For Digestive Organ Surgery: A comprehensive multi-institutional study on postoperative adjuvant immunotherapy with oral streptococcal preparation OK-432 for patients after gastric cancer surgery. Ann Surg 216: 44-54, 1992.
11. Wakasugi H, Kasahara T, Minato N, Hamuro J, Miyata M, Morioka Y: In vitro potentiation of human natural killer cell activity by a streptococcal preparation OK-432: Interferon and interleukin-2 participation in the stimulation with OK-432. JNCI 69: 807-812, 1982.
12. Yamamoto A, Nagamuta M, Usami H, Sugawara Y, Watanabe N, Niitsu Y, Urushizaki I: Release of tumor necrosis factor (TNF) into mouse peritoneal fluids by OK-432, Streptococcal preparation. Immunophamacology 11: 79-86, 1986.
13. International Union Against Cancer TNM Atlas. Illustrated Guide to the TNM/pTNM-Classification of Malignant Tumors. New York: Springer Verlag, 1993.
14. Dayer Jm, Beutler B, and Cerami A: Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 162: 2163-2168, 1985.
15. Patton JS, Shepard HM, Wilking H, Lewis G, Aggarwal BB, Eessalu TE, Gavin LA, Grunfeld C: Interferons and tumor necrosis factors have similar metabolic effects on 3T3-L1 cells. Proc Natl Acad Sci USA 83: 8313-8317, 1990.
16. Ogawa T, Ohwada S, Yasuo M: The combined immunochemotherapy with 5′-DFUR and OK-432 against AH66 ascites hepatoma in rats. Ann Cancer Res Ther 4: 21-24, 1995.